No cure for the summertime blues: The Tipline for 20 September 2019
Monday marks the official end of summer in the northern hemisphere, but Washington, DC, already feels autumnal. Beyond the cooling temperatures, the city seems ready to get down to serious business, with members of Congress holding hearings and proposing legislation on pocketbook issues including prescription drugs. House of Representatives antitrust subcommittee chair David Cicilline has put forward an anti-product-hopping bill to match one already in the Senate – sponsored by Republican John Cornyn. Hopefully bipartisanship will last long enough for some legislative accomplishments to occur.
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10